BioSpace News Archive

Business

IN8bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update

IN8bio, Inc. today announced financial results and operational highlights for the second quarter ended June 30, 2021.

September 10, 2021
·
9 min read
Pharm Country

Timber Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Timber Pharmaceuticals, Inc. today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

September 10, 2021
·
3 min read
Business

Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards

Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards

September 10, 2021
·
7 min read
Biotech Bay

Better Therapeutics to Participate in Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021

Better Therapeutics, Inc. has been invited to present at the Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference , which is being held virtually on September 14-15, 2021.

September 10, 2021
·
10 min read
Biotech Beach

Spinal Elements® Announces 100th Case With Sapphire X™ Anterior Cervical Fixation System

Spinal Elements today announced it has reached the milestone of completing 100 Sapphire X procedures after only a few weeks of commercialization.

September 10, 2021
·
2 min read
Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting

Revance Therapeutics, Inc. today announced that its data will be featured during the 2021 Virtual Skin of Color Update meeting, taking place September 10-12, 2021.

September 10, 2021
·
6 min read
Small Pharma to Present at Upcoming September Investor Conferences

Small Pharma Inc. will be presenting at the upcoming H.C. Wainwright 23rd Annual Global Investment Conference and the Maxim Group and M-Vest Advances in Mental Health Virtual Conference

September 10, 2021
·
2 min read
Drug Development

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

AzurRx BioPharma, Inc., a company specializing in the development of targeted non-systemic, therapies for gastrointestinal diseases, announced the activation of seven new clinical trial sites in India for the ongoing RESERVOIR trial evaluating FW-1022.

September 10, 2021
·
7 min read
Pharm Country

Life Sciences Virtual Investor Conference: Company Executives Present Live September 16thCompany executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world.

September 10, 2021
·
2 min read
Pharm Country

Akari Therapeutics to Present Its Phase III Plans for Nomacopan in Patients with Bullous Pemphigoid at the 2021 International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium

Akari Therapeutics, Plc today announced that Miles Nunn, Ph.D., Chief Scientific Officer of Akari Therapeutics, and Sanjeev Khindri, M.D., Medical Director of Akari Therapeutics, will present a poster at the 2021 International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium.

September 10, 2021
·
5 min read